Platinum Investment Management LTD Arcus Biosciences, Inc. Transaction History

Platinum Investment Management LTD

$2.43 Billion
Q1 2024

A detailed history of Platinum Investment Management LTD transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 204,398 shares of RCUS stock, worth $3.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

204,398

Previous 204,398 -0.0%

Holding current value

$3.11 Million

Previous $3.9 Million 1.15%

% of portfolio

0.16%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$17.62 - $23.54 $497,130 - $664,157	-28,214 Reduced 12.13%	204,398 $3.67 Million
Q1 2023 May 11, 2023	BUY	$15.96 - $23.15 $1.24 Million - $1.8 Million	77,761 Added 50.22%	232,612 $4.24 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $1.83 Million - $3.32 Million	93,071 Added 150.65%	154,851 $3.2 Million
Q3 2021 Nov 09, 2021	SELL	$26.93 - $37.68 $363,824 - $509,056	-13,510 Reduced 17.94%	61,780 $2.15 Million
Q1 2021 May 13, 2021	SELL	$26.16 - $41.39 $307,850 - $487,077	-11,768 Reduced 13.52%	75,290 $2.11 Million

Q2 2020 Aug 06, 2020	SELL	$13.97 - $36.56 $233,047 - $609,893	-16,682 Reduced 16.08%	87,058 $2.15 Million
Q4 2019 Feb 13, 2020	SELL	$7.33 - $10.79 $243,011 - $357,720	-33,153 Reduced 24.22%	103,740 $1.05 Million
Q3 2019 Nov 14, 2019	SELL	$6.44 - $10.18 $59,892 - $94,674	-9,300 Reduced 6.36%	136,893 $1.25 Million
Q4 2018 Feb 14, 2019	BUY	$9.74 - $14.5 $490,428 - $730,104	50,352 Added 52.54%	146,193 $1.57 Million
Q3 2018 Nov 15, 2018	BUY	$10.88 - $14.95 $467,840 - $642,850	43,000 Added 81.38%	95,841 $1.34 Million
Q2 2018 Aug 15, 2018	BUY	$12.24 - $17.05 $524,373 - $730,439	42,841 Added 428.41%	52,841 $647,000
Q1 2018 May 15, 2018	BUY	$15.44 - $17.71 $154,400 - $177,100	10,000 New	10,000 $154,000

Others Institutions Holding RCUS

# of Institutions

186

Shares Held

49.2M

Call Options Held

204K

Put Options Held

149K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.1B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account

Platinum Investment Management LTD Arcus Biosciences, Inc. Transaction History